Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Comparative Study of Cabaser and Sinemet CR For The Treatment Of Nocturnal Disability In Levodopa -Treated Parkinson's Disease Patients.

NCT00174239 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Comparative Study of Cabaser and Sinemet CR For The Treatment Of Nocturnal Disability In Levodopa -Treated Parkinson's Disease Patients.
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2004
Completion date
September 30, 2005
Enrollment
220
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease